Jyothy Labs

What does Jyothy Labs do?

Jyothy Laboratories Ltd. is a Mid Cap FMCG company that manufactures and markets consumer goods, with reported net sales of 667 Cr and net profit of 76 Cr for the quarter ending March 2025. Founded in 1983, it has a market cap of Rs 12,449 Cr and key metrics include a P/E of 34.00 and a dividend yield of 1.02%.

Overview: <BR>Jyothy Laboratories Ltd. is engaged in the manufacturing and marketing of various consumer goods in the FMCG sector and is categorized as a Mid Cap company.<BR><BR>History: <BR>Jyothy Laboratories Ltd. was incorporated on January 15, 1992, as a Private Limited Company, originally named 'Jyothi Laboratories Pvt., Ltd'. The company was founded by M. P. Ramachandran in 1983 in Thrissur, Kerala. The latest reported quarterly results indicate net sales and net profit for the period ending March 2025.<BR><BR>Financial Snapshot: <BR>Net Sales: 667 Cr (Quarterly Results - Mar 2025) <BR>Net Profit: 76 Cr (Quarterly Results - Mar 2025) <BR>Market Cap: Rs 12,449 Cr (Mid Cap)<BR><BR>Key Metrics: <BR>P/E: 34.00 <BR>Industry P/E: 54 <BR>Dividend Yield: 1.02% <BR>Debt Equity: -0.26 <BR>Return on Equity: 18.22% <BR>Price to Book: 6.15<BR><BR>Contact Details: <BR>Address: Ujala House Ram Krishna Mandir, Road Kondivita Andheri (E) Mumbai Maharashtra : 400059 <BR>Tel: 91-022-66892800 <BR>Email: info@jyothy.com <BR>Website: http://www.jyothylaboratories.com

What is the bonus history of the Jyothy Labs?

Jyothy Labs has issued bonuses twice, with a 1:1 bonus announced on June 28, 2018, and another 1:1 bonus on July 12, 2012, reflecting a consistent practice of rewarding shareholders.

Jyothy Labs has a history of issuing bonuses, with two notable instances. The most recent bonus was a 1:1 issue announced on June 28, 2018, with a record date of June 30, 2018. Prior to that, the company also issued a 1:1 bonus on July 12, 2012, with a record date of July 16, 2012. This indicates a consistent approach to rewarding shareholders through bonus shares.

Has Jyothy Labs declared dividend?

Yes, Jyothy Labs has declared a dividend of 350% (₹3.5 per share) with an ex-date of July 3, 2024. While recent short-term returns have been negative, long-term performance shows significant growth, particularly a total return of 200.75% over the last 5 years.

Jyothy Labs has declared a dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 350%<BR>- Amount per share: 3.5<BR>- Ex-date: 03 Jul 24<BR><BR>Dividend Yield: 1.02%.<BR><BR>Total Returns by Period:<BR>In the last 6 months, the price return was -19.58%, with no dividend return, resulting in a total return of -19.58%.<BR><BR>Over the past year, the price return was -24.07%, with a dividend return of 0.77%, leading to a total return of -23.3%.<BR><BR>In the 2-year period, the price return was 65.64%, with a dividend return of 3.04%, resulting in a total return of 68.68%.<BR><BR>For the 3-year period, the price return was 120.83%, with a dividend return of 5.91%, yielding a total return of 126.74%.<BR><BR>In the 4-year period, the price return was 113.76%, with a dividend return of 8.38%, culminating in a total return of 122.14%.<BR><BR>Over the last 5 years, the price return was 189.74%, with a dividend return of 11.01%, leading to a total return of 200.75%.<BR><BR>Overall, Jyothy Labs has declared a significant dividend, and while the recent short-term returns have been negative, the longer-term returns show substantial growth, particularly over the 5-year period.

Who are the peers of the Jyothy Labs?

Peers of Jyothy Labs include Hind. Unilever, ITC, Nestle India, Britannia Inds., Godrej Consumer, Zydus Wellness, CCL Products, Avanti Feeds, Honasa Consumer, and Mrs Bectors, with varying management risks and growth rates. Jyothy Labs has a 1-year return of -13.07%, better than Honasa Consumer but worse than Zydus Wellness, which leads with a 14.37% return.

Peers: The peers of Jyothy Labs are Hind. Unilever, ITC, Nestle India, Britannia Inds., Godrej Consumer, Zydus Wellness, CCL Products, Avanti Feeds, Honasa Consumer, and Mrs Bectors.<BR><BR>Quality Snapshot: Excellent management risk is observed at ITC, Nestle India, and Britannia Inds., while Good management risk is found at Hind. Unilever, Godrej Consumer, Jyothy Labs, CCL Products, and Avanti Feeds, and Average management risk is noted at Zydus Wellness and Honasa Consumer. In terms of Growth, Average growth is seen at Nestle India, while Below Average growth is present at Hind. Unilever, ITC, Britannia Inds., Godrej Consumer, Jyothy Labs, Zydus Wellness, CCL Products, Avanti Feeds, and Honasa Consumer, and the rest. For Capital Structure, Excellent capital structure is noted at Hind. Unilever, ITC, Nestle India, Britannia Inds., Godrej Consumer, Jyothy Labs, Zydus Wellness, Avanti Feeds, and Honasa Consumer, while Average capital structure is found at CCL Products.<BR><BR>Return Snapshot: Zydus Wellness has the highest 1-year return at 14.37%, while Honasa Consumer has the lowest at -32.21%, and Jyothy Labs' 1-year return of -13.07% is better than Honasa Consumer's but worse than Zydus Wellness'. Additionally, the six-month return is negative for Jyothy Labs, Hind. Unilever, ITC, Godrej Consumer, and Mrs Bectors.

Who are in the management team of Jyothy Labs?

As of March 2023, the management team of Jyothy Labs includes M P Ramachandran (Chairman Emeritus), M R Jyothy (Managing Director), Ramakrishnan Lakshminarayanan (Chairman & Independent Director), and several independent directors including Nilesh B Mehta, Bhumika Batra, and Aditya Sapru, along with Shreyas Trivedi as Company Secretary & Compliance Officer.

As of March 2023, the management team of Jyothy Labs includes the following individuals:<BR><BR>1. M P Ramachandran - Chairman Emeritus<BR>2. M R Jyothy - Managing Director<BR>3. Nilesh B Mehta - Independent Director<BR>4. Ramakrishnan Lakshminarayanan - Chairman & Independent Director<BR>5. Shreyas Trivedi - Company Secretary & Compliance Officer<BR>6. Bhumika Batra - Independent Director<BR>7. Aditya Sapru - Independent Director<BR><BR>These individuals play key roles in the governance and management of the company.

Who are the top shareholders of the Jyothy Labs?

The top shareholders of Jyothy Labs include promoter M G Shanthakumari with 39.12%, mutual funds at 14.9%, foreign institutional investors at 13.14%, and the largest public shareholder, Nalanda India Equity Fund Limited, holding 5.72%. Individual investors collectively own 6.78% of the shares.

The top shareholders of Jyothy Labs include several key players. The majority of the shares are held by promoters, with M G Shanthakumari being the promoter with the highest holding at 39.12%. Additionally, mutual funds hold 14.9% of the shares across 30 schemes, while foreign institutional investors (FIIs) own 13.14% through 162 different entities. The highest public shareholder is Nalanda India Equity Fund Limited, which holds 5.72%. Individual investors collectively hold 6.78% of the shares.

How big is Jyothy Labs?

As of 24th July, Jyothy Labs Ltd. has a market capitalization of 12,504.00 Cr, with net sales of 2,846.98 Cr and a net profit of 370.43 Cr reported in the latest four quarters.

As of 24th July, Jyothy Labs Ltd. has a market capitalization of 12,504.00 Cr, categorizing it as a Mid Cap company.<BR><BR>In the latest four quarters, Jyothy Labs reported net sales of 2,846.98 Cr and a net profit of 370.43 Cr.<BR><BR>The latest annual period for the balance sheet is March 2024, with shareholder's funds amounting to 1,808.31 Cr and total assets of 2,341.49 Cr.

Are Jyothy Labs latest results good or bad?

Jyothy Labs' latest results are concerning, with a decline in earnings per share to Rs 2.08 and only 1.35% net sales growth, down from 7.98% last year. The company has received a 'Hold' rating from MarketsMOJO, indicating a cautious outlook due to challenges in profitability and sustainability.

Jyothy Labs' latest results indicate a challenging period for the company. The earnings per share (EPS) for the quarter ending March 2025 is Rs 2.08, which is the lowest it has been in the past five quarters, suggesting a decline in profitability. Additionally, the company reported a year-over-year net sales growth of only 1.35%, a significant drop from 7.98% in the same quarter last year. <BR><BR>The standalone net profit also saw a decline of 4.95%, compared to a growth of 5.69% in the previous year, indicating that Jyothy Labs is facing difficulties in maintaining its profit levels. While there was a notable increase in non-operating income, this raises concerns about the sustainability of such income sources.<BR><BR>Given these factors, MarketsMOJO has issued a 'Hold' call on Jyothy Labs, reflecting a cautious outlook. Overall, the results suggest that the company's performance is currently flat and not favorable, highlighting the need for improvements in profitability and sustainable income sources moving forward.

Is Jyothy Labs technically bullish or bearish?

As of November 6, 2025, Jyothy Labs is in a bearish trend with moderate strength, supported by daily moving averages, bearish monthly MACD, and confirmation from Bollinger Bands and KST indicators.

As of 6 November 2025, the technical trend has changed from mildly bearish to bearish. The current stance is bearish with moderate strength. Key indicators driving this include the daily moving averages indicating a bearish trend, the weekly MACD showing mild bullishness but the monthly MACD remaining bearish, and both the weekly and monthly Bollinger Bands confirming a bearish outlook. Additionally, the KST is bearish on both weekly and monthly time frames, while the Dow Theory indicates a mildly bearish trend on the weekly chart. Overall, the combination of these indicators suggests a bearish sentiment for Jyothy Labs.

How has been the historical performance of Jyothy Labs?

Jyothy Labs has shown consistent growth in net sales and profitability, with net sales increasing from INR 1,711.17 crore in March 2020 to INR 2,846.98 crore in March 2025, and profit after tax rising from INR 162.58 crore to INR 370.38 crore in the same period. The company's total assets also grew significantly, reflecting its overall financial resilience.

Answer:<BR>The historical performance of Jyothy Labs shows a consistent growth trajectory in net sales and profitability over the years.<BR><BR>Breakdown:<BR>Jyothy Labs has demonstrated a steady increase in net sales from INR 1,711.17 crore in March 2020 to INR 2,846.98 crore in March 2025. This growth is accompanied by a rise in total operating income, which reached INR 2,846.98 crore in March 2025, up from INR 1,711.17 crore in March 2020. The company's operating profit (PBDIT) also reflects this positive trend, increasing from INR 271.08 crore in March 2020 to INR 555.17 crore in March 2025. Profit before tax has similarly improved, rising from INR 181.50 crore in March 2020 to INR 488.81 crore in March 2025. The profit after tax has shown a notable increase as well, from INR 162.58 crore in March 2020 to INR 370.38 crore in March 2025. In terms of assets, total assets grew from INR 1,733.49 crore in March 2020 to INR 2,663.44 crore in March 2025, while total liabilities increased from INR 1,733.49 crore to INR 2,663.44 crore in the same period. The cash flow from operating activities has fluctuated, peaking at INR 457 crore in March 2024 but dropping to INR 311 crore in March 2025. Overall, Jyothy Labs has shown resilience and growth in its financial performance over the years.

Should I buy, sell or hold Jyothy Labs?

Is Jyothy Labs overvalued or undervalued?

As of December 3, 2025, Jyothy Labs is considered very attractive and undervalued, with a PE ratio of 28.70 and strong financial metrics, making it a compelling investment opportunity despite a year-to-date stock performance lagging behind the Sensex.

As of 3 December 2025, the valuation grade for Jyothy Labs has moved from attractive to very attractive, indicating a significant positive shift in its perceived value. The company is currently assessed as undervalued. Key ratios include a PE ratio of 28.70, an EV to EBITDA of 20.38, and a ROCE of 29.33%. <BR><BR>In comparison to its peers, Jyothy Labs stands out as relatively undervalued, especially when compared to Hindustan Unilever, which has a PE ratio of 54.52, and Nestle India at 79.74. Despite recent stock performance lagging behind the Sensex, with a year-to-date return of -26.53% versus the Sensex's 8.92%, the strong financial metrics suggest that Jyothy Labs presents a compelling investment opportunity in the FMCG sector.

When is the next results date for Jyothy Labs Ltd.?

The next results date for Jyothy Labs Ltd. is 09 February 2026.

The next results date for Jyothy Labs Ltd. is scheduled for 09 February 2026.

Which are the latest news on Jyothy Labs?

Why is Jyothy Labs Ltd. falling/rising?

As of 08-Feb, Jyothy Labs Ltd. is facing a stock price decline to 243.65, down 0.25%. This is due to significant underperformance against the Sensex, declining investor participation, and poor long-term growth prospects.

As of 08-Feb, Jyothy Labs Ltd. is experiencing a decline in its stock price, currently at 243.65, reflecting a change of -0.6 (-0.25%). This downward movement can be attributed to several factors highlighted in the provided data. <BR><BR>Firstly, the stock has significantly underperformed compared to the benchmark Sensex, with a 1-year return of -39.24% against the Sensex's positive return of +7.07%. Over the past month, the stock has also dropped by 13.51%, while the Sensex fell only 1.74%. This trend indicates a consistent underperformance relative to the broader market.<BR><BR>Additionally, Jyothy Labs is trading below its moving averages across various periods, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, which typically signals a bearish trend. The stock is also close to its 52-week low, being just 1.95% away from the low of Rs 238.9.<BR><BR>Investor participation appears to be declining, as evidenced by a 17.92% drop in delivery volume compared to the 5-day average. This reduced activity may reflect waning investor confidence in the stock. <BR><BR>Moreover, despite some positive factors such as high management efficiency and low debt levels, the company has shown poor long-term growth, with net sales growing at an annual rate of only 10.71% over the last five years. The flat results reported for March 2025, including the lowest debtors turnover ratio and cash equivalents, further contribute to the negative sentiment surrounding the stock.<BR><BR>In summary, the combination of significant underperformance against market benchmarks, declining investor participation, and poor long-term growth prospects are key reasons for the falling stock price of Jyothy Labs Ltd.